Skip to main content
. 2021 Feb 22;28:32–38. doi: 10.1016/j.ctro.2021.02.006

Table 1.

Dose and coverage parameters per organ at risk or target volume for VMAT and IMPT.

Organs at risk VMAT D2% IMPT D2%
Brain 55.1 (4.6) 54.9 (1.3)
Brainstem 51.3 (16.3) 50.9 (17.0)
Optic chiasm 31.8 (23.1) 26.1 (27.4)
Cornea ipsi and bilateral 10.1 (8.0) 4.4 (7.1)*
Cornea contralateral 4.3 (3.8) <0.01 (<0.01)*
Lens ipsi and bilateral 3.5 (2.9) 0.96 (1.9)*
Lens contralateral 1.9 (2.4) <0.01 (<0.01)*
Optic nerve ipsi and bilateral 30.8 (23.9) 28.3 (26.6)
Optic nerve contralateral 8.2 (6.8) 0.065 (0.16)*
Retina ipsi and bilateral 12.2 (10.0) 7.5 (11.5)*
Retina contralateral 4.6 (4.2) <0.01 (<0.01)*
Spinal cord 7.7 (17.0) 10.5 (18.5)



Organ at risk VMAT D40% IMPT D40%
Hippocampus ipsi and bilateral 17.6 (14.7) 11.4 (16.0)*
Hippocampus contralateral 5.6 (3.6) 1.0 (1.7)*



Organs at risk/target volume VMAT Dmean IMPT Dmean
Brain 11,2 (3.9) 7.9 (3.0)*
Cerebellum anterior – CTV 26.5 (11.2) 15.2 (15.0)*
Cerebellum posterior – CTV 17.6 (10.9) 10.7 (12.9)
Cochlea ipsi and bilateral 14.3 (9.6) <0.01*
Cochlea contralateral 6.0 (6.0) 0.071 (0.065)*
Hippocampus ipsi and bilateral 17.2 (12.8) 11.1 (12.8)*
Hippocampus contralateral 5.7 (3.9) 1.7 (3.2)*
Lacrimal gland ipsi and bilateral 8.8 (7.5) 3.3 (5.8)*
Lacrimal gland contralateral 3.7 (3.7) <0.01 (<0.01)*
Supratentorial brain – CTV 9.3 (4.3) 6.5 (3.8)*
Pituitary gland 26.5 (24.2) 23.4 (26.4)
Integral dose to the body 6.5 (2.5) 4.5 (2.1)*
CTV54Gy 57.2 (2.4) 55.6 (2.0)*
GTV 57.0 (2.5) 55.4 (1.9)*



CN VMAT D95% IMPT D95%
CTV54Gy 0,62 (0.068) 0,57 (0.11)*

D2%: dose to 2% of the volume reported in Gy(RBE); D40%: dose to 40% of the volume reported in Gy(RBE); Dmean: mean dose to organ at risk or target volume in Gy(RBE); D95%: dose to 95% of the volume reported in Gy(RBE) CTV54Gy: Volume of the CTV receiving 54 Gy; CN: conformity number. Numbers between parentheses are standard deviations. * numbers with asterisk are statistically significantly different (p < 0.05).